In this podcast episode, Dr. Fred Tenover, Vice President of Scientific Affairs for Cepheid, discusses:
- The evolution of COVID testing
- How Cepheid differentiates themselves when it comes to COVID testing
- What types of customers are best for the CLIA-waived molecular systems and the Xpert Xpress systems
- COVID-19 mutations and their impact on the performance of testing
- The challenges physicians face as respiratory season approaches